AstraZeneca PLC Correlations
| AZNCF Stock | USD 153.42 1.22 0.79% |
The current 90-days correlation between AstraZeneca PLC and Roche Holding AG is 0.15 (i.e., Average diversification). The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
AstraZeneca PLC Correlation With Market
Good diversification
The correlation between AstraZeneca PLC and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and DJI in the same portfolio, assuming nothing else is changed.
AstraZeneca |
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC to buy it.
Moving together with AstraZeneca Pink Sheet
| 0.76 | LLY | Eli Lilly | PairCorr |
| 0.93 | JNJ | Johnson Johnson | PairCorr |
| 0.92 | RHHBF | Roche Holding AG | PairCorr |
| 0.94 | RHHBY | Roche Holding | PairCorr |
| 0.95 | RHHVF | Roche Holding AG | PairCorr |
| 0.96 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.94 | NVS | Novartis AG ADR | PairCorr |
| 0.91 | NVSEF | Novartis AG | PairCorr |
| 0.76 | CTDD | Qwest Corp 6 | PairCorr |
| 0.78 | CTBB | Qwest Corp NT | PairCorr |
| 0.91 | RBKB | Rhinebeck Bancorp | PairCorr |
| 0.92 | CHKP | Check Point Software | PairCorr |
| 0.62 | TRGGF | Tarachi Gold Corp | PairCorr |
| 0.9 | ASA | ASA Gold Normal Trading | PairCorr |
| 0.71 | SATS | EchoStar | PairCorr |
| 0.72 | RBC | RBC Bearings | PairCorr |
| 0.62 | STLD | Steel Dynamics | PairCorr |
| 0.68 | DASH | DoorDash, Class A | PairCorr |
| 0.63 | BB | BlackBerry | PairCorr |
Moving against AstraZeneca Pink Sheet
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between AstraZeneca Pink Sheet performing well and AstraZeneca PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AstraZeneca PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RHHVF | 1.19 | 0.29 | 0.27 | (3.67) | 1.02 | 2.72 | 6.16 | |||
| RHHBF | 2.36 | 0.26 | 0.11 | (0.45) | 2.71 | 6.60 | 17.19 | |||
| RHHBY | 1.02 | 0.32 | 0.28 | 0.95 | 0.93 | 2.63 | 5.52 | |||
| GRFS | 2.31 | 0.07 | 0.06 | (0.18) | 2.76 | 5.64 | 15.06 | |||
| BAYZF | 1.59 | 0.34 | 0.22 | 1.49 | 1.36 | 4.02 | 12.61 | |||
| ALPMF | 0.71 | (0.05) | 0.00 | (0.48) | 0.00 | 2.11 | 10.41 | |||
| ALPMY | 0.91 | (0.04) | 0.00 | (0.20) | 0.00 | 1.77 | 5.97 | |||
| BAYRY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BMYMP | 3.46 | 0.38 | 0.05 | 0.41 | 4.58 | 12.78 | 32.90 | |||
| DSKYF | 4.06 | (0.10) | 0.00 | (0.20) | 0.00 | 8.22 | 21.07 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
AstraZeneca PLC Corporate Management
| Chris Sheldon | Head Relations | Profile | |
| MBA DVM | CEO Director | Profile | |
| Gonzalo Vina | Head Relations | Profile | |
| Aradhana MD | CFO Director | Profile |